US Stock MarketDetailed Quotes
GLSI Greenwich LifeSciences
- 12.070
- -0.820-6.36%
Close Apr 19 16:00 ET
- 12.000
- -0.070-0.58%
Post 16:07 ET
155.44MMarket Cap-17492P/E (TTM)
13.175High12.020Low30.69KVolume12.750Open12.890Pre Close382.08KTurnover0.53%Turnover RatioLossP/E (Static)12.88MShares21.44052wk High23.21P/B70.55MFloat Cap7.58052wk Low--Dividend TTM5.84MShs Float158.070Historical High--Div YieldTTM8.96%Amplitude3.262Historical Low12.451Avg Price1Lot Size
About Greenwich LifeSciences Company
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Company Profile
SymbolGLSI
Company NameGreenwich LifeSciences
Listing DateSep 25, 2020
Issue Price5.75
Founded2006
CEOMr. Snehal S. Patel
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3992 Bluebonnet Drive,Building 14
CityStafford
ProvinceTexas
CountryUnited States of America
Zip Code77477
Phone1-832-819-3232
Company Executives
- Name
- Position
- Salary
- Snehal S. Patel
- Principal Accounting Officer, Chief Executive Officer, Chief Financial Officer and Director
- 2.21M
- Dr. F Joseph. Daugherty
- Chief Medical Officer and Director
- --
- Dr. Jaye Thompson, M.S.,PhD
- Vice President, Clinical and Regulatory Affairs
- --
- David B. McWilliams
- Chairman of the Board
- 65.01K
- Kenneth Hallock
- Independent Director
- 43.37K
- Eric Rothe
- Independent Director
- 43.37K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg